Vanda Pharmaceuticals Inc.

VNDA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001347178

SEC filings (opens in a new tab)

No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Vanda Pharmaceuticals Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of VNDA: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	150	2	153	+5
Shares	44.9M	64.1K	41.9M	−2.94M (−6.5%)
Value	$224.0M	$319.7K	$369.4M	+$145.7M (+65.1%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to VNDA in Q4 2025
Institution	Shares	Value	% of portfolio
AIGH Capital Management LLC	1,998,431	$17.6M	5.21%
Trexquant Investment LP	204,491	$1.80M	0.02%
Janney Montgomery Scott LLC	175,541	$1.55M	0.00%
Kotler Kevin	100,000	$882.0K	0.65%
Balyasny Asset Management LLC	68,178	$601.3K	0.00%
Point72 Asset Management, L.P.	61,466	$542.1K	0.00%
Schonfeld Strategic Advisors LLC	59,107	$521.3K	0.00%
StemPoint Capital LP	58,989	$520.3K	0.09%
Brevan Howard Capital Management LP	53,062	$468.0K	0.01%
Axq Capital, LP	26,557	$234.2K	0.05%
Canada Pension Plan Investment Board	23,100	$203.7K	0.00%
Graham Capital Management, L.P.	23,060	$203.4K	0.01%
Prelude Capital Management, LLC	15,100	$133.2K	0.01%
Sassicaia Capital Advisers LLC	14,700	$129.7K	0.28%
SG Americas Securities, LLC	10,807	$95.0K	0.00%
Jain Global LLC	10,651	$93.9K	0.00%
Torren Management, LLC	2,779	$24.5K	0.01%
Costello Asset Management, INC	2,500	$22.1K	0.01%
Versant Capital Management, Inc	2,362	$20.8K	0.00%
Robertson Stephens Wealth Management, LLC	600	$5.29K	0.00%
Basecamp Wealth Advisors LLC	553	$4.88K	0.00%
Signaturefd, LLC	499	$4.40K	0.00%
Los Angeles Capital Management LLC	481	$2.08K	0.00%
SageView Advisory Group, LLC	225	$1.99K	0.00%
Rockefeller Capital Management L.P.	200	$1.76K	0.00%
SHP Wealth Management	50	$441	0.00%
SJS Investment Consulting Inc.	21	$186	0.00%
MAI Capital Management	6	$53	0.00%

Sold out (23)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of VNDA in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Tang Capital Management LLC	2,353,307	$11.7M
Marshall Wace, LLP	581,247	$2.90M
Prudential Financial Inc	449,403	$2.24M
Citadel Advisors LLC	263,806	$1.32M
Stonepine Capital Management, LLC	195,000	$973.0K
Profit Investment Management, LLC	186,400	$930.1K
ExodusPoint Capital Management, LP	68,103	$339.8K
PharVision Advisers, LLC	57,037	$284.6K
Algert Global LLC	34,934	$174.3K
Nomura Holdings Inc	30,487	$152.1K
XTX Topco Ltd	30,121	$150.3K
Readystate Asset Management LP	27,610	$137.8K
Bailard, Inc.	26,169	$130.6K
Caption Management, LLC	22,067	$110.1K
Envestnet Asset Management Inc	16,822	$83.9K
Boothbay Fund Management, LLC	14,446	$72.1K
Engineers Gate Manager LP	12,867	$64.2K
HRT Financial LP	11,280	$56.0K
Quarry LP	10,702	$53.4K
HighTower Advisors, LLC	7,490	$37.4K
Advisory Services Network, LLC	21	$105
Covestor Ltd	66	$0
Summit Wealth Group LLC	1,843	–

Not filed for Q4 2025 yet (2)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VNDA in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Cubist Systematic Strategies, LLC	63,821	$318.5K
Point72 Europe (London) LLP	245	$1.22K